PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A new route for tackling treatment-resistant prostate cancer

2012-07-25
(Press-News.org) Scientists have identified what may be the Peyton Manning of prostate cancer. It's a protein that's essential for the disease to execute its game plan: Grow and spread throughout the body.

Like any good quarterback, this protein has command over the entire field; not only does it control cell growth in tumors that are sensitive to hormone therapy, a common treatment for men with advanced disease, but also in tumors that grow resistant to such treatment – a dismal development that leaves men and their doctors with no good options to turn to.

In a study published in the Journal of Clinical Investigation, a team led by scientists from the University of Rochester Medical Center found that the protein paxillin is a major player in prostate cancer, the second most common form of cancer in men. Though in the very early stages, the discovery is an important first step towards developing a treatment for men whose cancer prevails even after the most aggressive treatment.

"The holy grail in prostate cancer is to figure out why cells stop responding to hormone therapy," said senior study author Stephen R. Hammes, M.D., Ph.D., chief of the Division of Endocrinology and Metabolism at the Medical Center. Initially, hormone therapy, which starves tumors of the hormones that fuel their growth, works well and may lead to remission. But, according to the American Cancer Society, nearly all prostate cancers treated with hormone therapy become resistant over a period of months or years and the cancer makes an unwelcome comeback.

"Somehow, tumors find a way to grow even when their main power source is choked off," noted Hammes, also the Louis S. Wolk Distinguished Professor in Medicine. "Our work is exciting because we've identified a protein pathway that controls growth even in the absence of hormones and provides a completely new treatment target for the disease."

Hammes and first author Aritro Sen, Ph.D., Research Assistant Professor in the Division of Endocrinology and Metabolism, knew from their previous research that paxillin is important in prostate cancer, but they didn't know why or how.

They found that under certain conditions the protein, which normally hangs out in the cytoplasm or gel-like substance that fills a cell, actually goes into the nucleus – the cell's genetic powerhouse. There, it's an extremely commanding force, regulating signals that lead to the creation of cancer cells.

"This is the first time anyone's shown that paxillin goes into the nucleus and controls gene expression," said Sen. "When we eliminated this protein from prostate cancer cells their growth was significantly arrested, but what surprised us most was that this effect was identical in both hormone therapy-dependent as well as resistant prostate cancer cells."

In typical tumors stimulated by male hormones called androgens, paxillin partners with the hormones to turn on genes that lead to the creation of more cancer cells. Such tumors shrink, at least for a time, when subject to hormone therapy.

But for tumors that continue to grow despite hormone therapy – called castration-resistant prostate cancer – Hammes' team found that paxillin takes another route and connects with naturally occurring substances called growth factors to activate genes that produce more cancer cells.

Take paxillin out of the nucleus and growth comes to a halt: Without it, genes directed by androgens don't get turned on, nor do genes directed by growth factors.

"Lots of pathways are being examined as scientists look for what makes a prostate cancer cell become castration resistant, but ours is a completely novel approach," says Hammes of the paxillin-mediated pathway.

Sen adds, "We have now found a common factor that regulates both hormone-dependent and castration-resistant prostate cancer cells."

Edward M. Messing, M.D., chair of the Department of Urology at the Medical Center and a world-renowned expert in the diagnosis and treatment of prostate cancer, says "This is a potentially important observation since, as of now, most cancers eventually escape available means of inactivating androgens and their receptor. If paxillin proves to be a major new pathway, interfering with it may extend life or even cure men with far advanced prostate cancer, a stage of the disease which until now has always proved lethal."

The team conducted multiple tests to confirm the power of paxillin in prostate cancer. They found that paxillin is ramped up in tissue from human tumors, much more so than in normal cells. And in mice with human prostate cancer cells, getting rid of paxillin caused the tumors to grow more slowly.

Hammes says the next step is to figure out how to stop paxillin from getting into the nucleus, or to inhibit its activity once it's in the nucleus. "Paxillin has important functions in the cytoplasm, like helping cells communicate with each other to form organs and other structures," he noted. "If we can target paxillin in the nucleus where it mediates cancer cell growth, but leave it intact in the cytoplasm so it can continue to do the important work it does there, that would be the goal."

Like any targeted cancer therapy, the team wants to hurt the cells that are proliferating, and leave the healthy cells that are standing still alone, says Hammes.

###In addition to Hammes and Sen, Ismary De Castro, M.D. and Randall Rossi at the Medical Center contributed to the research. Donald B. DeFranco, Ph.D., University of Pittsburgh, Fang-Ming Deng, M.D., Ph.D. and Jonathan Melamed, M.D., New York University School of Medicine, and Payel Kapur, M.D. and Ganesh V. Raj, M.D., Ph.D., University of Texas Southwestern Medical Center, also participated in the research.

The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health and the University of Rochester Medical Center. The University has filed a patent application on using paxillin as a biomarker for prostate cancer diagnosis as well as using paxillin as a therapeutic target for prostate cancer treatment.


ELSE PRESS RELEASES FROM THIS DATE:

Carnivores: Beware of ticks

2012-07-25
If you are a steak lover, enjoy your meat while you can. An article by Susan Wolver, MD, and Diane Sun, MD, from Virginia Commonwealth University in the US, and colleagues, explains why if you have been bitten by a tick, you may develop an allergy to red meat. Their article1 elucidates this connection and discusses the journey of the discovery. Their work appears online in the Journal of General Internal Medicine², published by Springer. Delayed anaphylaxis - a severe, life-threatening allergic reaction - to meat is a new syndrome identified initially in the southeastern ...

Blue Ribbon Panel unveils findings on logistical improvements to support Antarctic science

2012-07-25
Today, the 12-member U.S. Antarctic Program Blue Ribbon Panel, commissioned by the White House Office of Science and Technology Policy (OSTP) and the National Science Foundation (NSF) released their report, More and Better Science in Antarctica through Increased Logistical Effectiveness. The report is a comprehensive document based on several months of research, containing numerous specific recommendations for the U.S. logistics system for improved support of scientific research in Antarctica and the Southern Ocean. "The Antarctica Blue Ribbon Panel encourages us to take ...

QM historians discover medieval banking records hidden under coats of arms

2012-07-25
A rare accounting document, half-concealed beneath a coat of arms design, has revealed the activities of Italian bankers working in early 15th century London, decades before the capital became a financial powerhouse. The discovery was made by economic historians at Queen Mary, University of London. Among the pages of a bound collection of traditional English crests held at the London College of Arms - the headquarters of British heraldry - are several papers belonging to a book of debtors and creditors for Florentine merchant-banking company, Domenicio Villani & Partners. The ...

Internists say physician-led quality initiatives could be solution to Medicare payment problems

2012-07-25
(Washington) – "Repeal of Medicare's Sustainable Growth Rate (SGR) is essential, but repeal by itself will not move Medicare to better ways to deliver care," David L. Bronson, MD, FACP, president of the American College of Physicians (ACP), today told the House Ways and Means Subcommittee on Health. "We need to transition from a fundamentally broken physician payment system to one that is based on the value of services to patients, building on physician-led initiatives to improve outcomes and lower costs." Dr. Bronson described how physician organization's efforts and ...

Satellites see unprecedented Greenland ice sheet surface melt

2012-07-25
WASHINGTON -- For several days this month, Greenland's surface ice cover melted over a larger area than at any time in more than 30 years of satellite observations. Nearly the entire ice cover of Greenland, from its thin, low-lying coastal edges to its 2-mile-thick center, experienced some degree of melting at its surface, according to measurements from three independent satellites analyzed by NASA and university scientists. On average in the summer, about half of the surface of Greenland's ice sheet naturally melts. At high elevations, most of that melt water quickly ...

Ecopsychology -- a major new area of study

2012-07-25
New Rochelle, NY, July 24, 2012—Hundreds of colleges and universities around the world are offering courses and even graduate degrees in ecopsychology and other forms of environmentally focused psychology. Ecopsychology examines the psychological, spiritual, and therapeutic aspects of human-nature relationships, concern about environmental issues, and responsibility for protecting natural places and other species. Educators are increasingly recognizing the value of integrating psychology and environmental content to help students appreciate the link between their own well-being ...

Identifying trending stories on Twitter and optimal temperature for data center computers

2012-07-25
Papers on how best to identify trending stories on Twitter and on just how cool computers in data centers need to be kept has won accolades for faculty and students from UTSC's Department of Computer & Mathematical Sciences. Nick Koudas, UTSC computer science professor, and his graduate students Albert Angel and Nikos Sarkas, won the Best Paper award for the Very Large Databases Conference, which they will present at the meeting in Istanbul in August. The paper presents a new way of identifying stories of interest on Twitter and other streaming microblogging sites. ...

'Weakest links' show greatest gains in relay races

2012-07-25
EAST LANSING, Mich. — The inferior members of swimming or running relay teams – those athletes who fared poorest in individual races – showed the greatest gains when performing as part of a team, and those gains were even greater during final races as opposed to preliminary races. The new research from Michigan State University's Deborah Feltz and Kaitlynn Osborn provides some of the first real-world support for the Köhler motivation effect, which describes how less capable individuals perform better when performing a task with others as opposed to individually. The ...

Reducing traffic at 2008 Olympics yielded large cut in CO2

2012-07-25
Contact: David Hosansky hosansky@ucar.edu 303-497-8611 Zhenya Gallon zhenya@ucar.edu 303-497-8607 National Center for Atmospheric Research/University Corporation for Atmospheric Research Reducing traffic at 2008 Olympics yielded large cut in CO2 BOULDER—China's Olympian attempt to improve air quality during the 2008 summer games did more than provide a healthier atmosphere for the athletes. It also demonstrated that widespread changes in transportation patterns could greatly reduce the threat of climate change. New research by an international team ...

Colonoscopy screening markedly reduces colorectal cancer incidence and death

2012-07-25
OAK BROOK, Ill. – JULY 24, 2012 – A study from researchers in Switzerland found that colonoscopy with polypectomy significantly reduces colorectal cancer incidence and colorectal cancer-related death in the general population. A total of 12 colorectal cancer cases were identified in the screening group of 1,912 patients and 213 cases of colorectal cancer were found in the non-screened group of 20,774 patients. One of the 12 persons of the screened individuals with a colorectal cancer and 51 of the 213 persons of the non-screened individuals with a colorectal cancer died ...

LAST 30 PRESS RELEASES:

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

Cardiovascular health changes in young adults and risk of later-life cardiovascular disease

Nurse workload and missed nursing care in neonatal intensive care units

How to solve the remote work stalemate – dissertation offers tools for successful hybrid work

Chip-based phonon splitter brings hybrid quantum networks closer to reality

Texas Children’s researchers create groundbreaking tool to improve accuracy of genetic testing

Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals

Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award

[Press-News.org] A new route for tackling treatment-resistant prostate cancer